China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

1 Drugs for Treatment of Prostate Cancer Overview and Each Type

1.1 Product Overview of Prostate Cancer

1.1.1 Definition and Product Scope of Drugs for Prostate Cancer

1.1.2 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021

1.1.3 Russia Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021

1.1.4 Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021

1.1.5 Japan Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021

1.2 Product Segments and Price of Each Type

1.2.1 Product Type of Key Manufacturers

1.2.2 Price List and of Each Type 2015 to 2016

1.2.3 Market Share and Growth Rate of Each Type

1.2.4 Triptorelin and Specification

1.2.5 Leuprorelin and Specification

1.2.6 Flutamide Tablets and Specification

1.2.7 Goserelin and Specification

1.2.8 Bicalutamide Tablets and Specification

1.2.9 Bicalutamide Capsules and Specification

1.2.10 Estramustine Phosphate Capsules and Specification

1.2.11 Mitoxantrone and Specification

1.2.12 Zytiga and Specification

1.2.13 Xtandi and Specification

1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016

1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers

1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers

1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers

1.3.4 Price List (Interviewed) of Goserelin by Manufacturers

1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers

1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers

1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers

1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers

1.3.9 Price List (Interviewed) of Zytiga by Manufacturers

1.3.10 Price List (Interviewed) of Xtandi by Manufacturers

2 Competition Analysis by Manufacturers in Global and China

2.1 Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016

2.2 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015

2.3 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015

2.4 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

2.5 Russia Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015

2.6 Russia Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015

2.7 Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

2.8 Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015

2.9 Brazil Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015

2.10 Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

2.11 Japan Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015

2.12 Japan Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015

2.13 Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

3 Sales and Revenue Segments of Each Type 2010 to 2015

3.1 China Sales and Revenue Segments of Each Type 2010 to 2015

3.1.1 China Sales and Market Share of Each Type 2010 to 2015

3.1.2 China Sales Growth Rate of Each Type 2015 to 2016

3.1.3 China Revenue and Market Share of Each Type 2015 to 2016

3.1.4 China Revenue and Market Share of Each Type 2015 to 2016

3.2 Russia Sales and Revenue Segments of Each Type 2015 to 2016

3.2.1 Russia Sales and Market Share of Each Type 2015 to 2016

3.2.2 Russia Sales Growth Rate of Each Type 2015 to 2016

3.2.3 Russia Revenue and Market Share of Each Type 2015 to 2016

3.2.4 Russia Revenue and Market Share of Each Type 2015 to 2016

3.3 Brazil Sales and Revenue Segments of Each Type 2015 to 2016

3.3.1 Brazil Sales and Market Share of Each Type 2015 to 2016

3.3.2 Brazil Sales Growth Rate of Each Type 2015 to 2016

3.3.3 Brazil Revenue and Market Share of Each Type 2015 to 2016

3.3.4 Brazil Revenue and Market Share of Each Type 2015 to 2016

3.4 Japan Sales and Revenue Segments of Each Type 2015 to 2016

3.3.1 Japan Sales and Market Share of Each Type 2015 to 2016

3.3.2 Japan Sales Growth Rate of Each Type 2015 to 2016

3.3.3 Japan Revenue and Market Share of Each Type 2015 to 2016

3.3.4 Japan Revenue and Market Share of Each Type 2015 to 2016

4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions

4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021

4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021

4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021

5 Raw Materials and Applications

5.1 Key Raw Materials and Price Analysis for Triptorelin

5.1.1 Key Raw Materials for Triptorelin

5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021

5.2 Key Raw Materials and Price Analysis for Leuprorelin

5.2.1 Key Raw Materials for Leuprorelin

5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021

5.3 Key Raw Materials and Price Analysis for Flutamide Tablets

5.3.1 Key Raw Materials for Flutamide Tablets

5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021

5.4 Key Raw Materials and Price Analysis for Goserelin

5.4.1 Key Raw Materials for Goserelin

5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021

5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets

5.5.1 Key Raw Materials for Bicalutamide Tablets

5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021

5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules

5.6.1 Key Raw Materials for Bicalutamide Capsules

5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021

5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules

5.7.1 Key Raw Materials for Estramustine Phosphate Capsules

5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021

5.8 Key Raw Materials and Price Analysis for Mitoxantrone

5.8.1 Key Raw Materials for Mitoxantrone

5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021

5.9 Key Raw Materials and Price Analysis for Zytiga

5.9.1 Key Raw Materials for Zytiga

5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021

5.10 Key Raw Materials and Price Analysis for Xtandi

5.10.1 Key Raw Materials for Xtandi

5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021

5.11 Applications of Triptorelin

5.12 Applications of Leuprorelin

5.13 Applications of Flutamide Tablets

5.14 Applications of Goserelin

5.15 Applications of Bicalutamide Tablets

5.16 Applications of Bicalutamide Capsules

5.17 Applications of Estramustine Phosphate Capsules

5.18 Applications of Mitoxantrone

5.19 Applications of Zytiga

5.20 Applications of Xtandi

6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer

6.1 IPSEN

6.1.1 IPSEN Basic Information

6.2.2 Triptorelin (Specification and Price)

6.2.3 Sales Value, Gross Margin 2011-2016

6.1.4 Interviewee, Name and Contact

6.2 Ferring Pharmaceuticals

6.2.1 Company Basic Information

6.2.2 Triptorelin (Specification and Price)

6.2.3 Sales Value, Gross Margin 2011-2016

6.2.4 Interviewee, Name and Contact

6.3 Chengdu Tiantaishan pharmaceutical

6.3.1 Company Basic Information

6.3.2 Triptorelin (Specification and Price)

6.3.3 Sales Value, Gross Margin 2011-2016

6.3.4 Interviewee, Name and Contact

6.4 GeneScience Pharmaceuticals

6.4.1 Company Basic Information

6.4.2 Triptorelin (Specification and Price)

6.4.3 Sales Value, Gross Margin 2011-2016

6.4.4 Interviewee, Name and Contact

6.5 Takeda Pharmaceutical Company Limited

6.5.1 Company Basic Information

6.5.2 Leuprorelin (Specification and Price)

6.5.3 Sales Value, Gross Margin 2011-2016

6.5.4 Interviewee, Name and Contact

6.6 Beijing Biote Pharmaceutical

6.6.1 Company Basic Information

6.6.2 Leuprorelin (Specification and Price)

6.6.3 Sales Value, Gross Margin 2011-2016

6.6.4 Interviewee, Name and Contact

6.7 Livzon Pharmaceutical Group

6.7.1 Company Basic Information

6.7.2 Leuprorelin (Specification and Price)

6.7.3 Sales Value, Gross Margin 2011-2016

6.7.4 Interviewee, Name and Contact

6.8 Schering-Plough Canada

6.8.1 Company Basic Information

6.8.2 Flutamide Tablets (Specification and Price)

6.8.3 Sales Value, Gross Margin 2011-2016

6.8.3 Sales Value, Gross Margin 2011-2016

6.8.3 Sales Value, Gross Margin 2011-2016

6.8.3 Sales Value, Gross Margin 2011-2016

6.8.4 Interviewee, Name and Contact

6. 9 JiangSu TASLY DI YI Pharmaceutical

6.9.1 Company Basic Information

6.9.2 Flutamide Tablets (Specification and Price)

6.9.3 Sales Value, Gross Margin 2011-2016

6.9.4 Interviewee, Name and Contact

6.10 Shanghai Fudan Fuhua Pharmaceutical

6.10.1 Company Basic Information

6.10.2 Flutamide Tablets (Specification and Price)

6.10.3 Sales Value, Gross Margin 2011-2016

6.10.4 Interviewee, Name and Contact

6.11 S.C.SINDAN-PHARMA S.R.L.

6.11.1 Company Basic Information

6.11.2 Flutamide Tablets (Specification and Price)

6.11.3 Sales Value, Gross Margin 2011-2016

6.11.4 Interviewee, Name and Contact

6.12 AstraZeneca

6.12.1 Company Basic Information

6.12.2 Goserelin (Specification and Price)

6.12.3 Sales Value, Gross Margin 2011-2016

6.12.4 Interviewee, Name and Contact

6.13 Corden Pharma GmbH

6.13.1 Company Basic Information

6.13.2 Bicalutamide Tablets (Specification and Price)

6.13.3 Sales Value, Gross Margin 2011-2016

6.13.4 Interviewee, Name and Contact

6.14 Shanghai Zhaohui Pharmaceutical

6.14.1 Company Basic Information

6.14.2 Bicalutamide Tablets (Specification and Price)

6.14.3 Sales Value, Gross Margin 2011-2016

6.14.4 Interviewee, Name and Contact

6.15 HISUN Pharmaceutical

6.15.1 Company Basic Information

6.15.2 Bicalutamide Tablets (Specification and Price)

6.15.3 Sales Value, Gross Margin 2011-2016

6.15.4 Interviewee, Name and Contact

6.16 Shanxi Zhendong Pharmaceutical

6.16.1 Company Basic Information

6.16.2 Bicalutamide Capsules (Specification and Price)

6.16.3 Sales Value, Gross Margin 2011-2016

6.16.4 Interviewee, Name and Contact

6.17 Pfizer

6.17.1 Company Basic Information

6.17.2 Estramustine Phosphate Capsules (Specification and Price)

6.17.3 Sales Value, Gross Margin 2011-2016

6.17.4 Interviewee, Name and Contact

6.18 Sichuan sunnyhope pharmaceutical

6.18.1 Company Basic Information

6.18.2 Mitoxantrone (Specification and Price)

6.18.3 Sales Value, Gross Margin 2011-2016

6.18.4 Interviewee, Name and Contact

6.19 Luoxin Group

6.19.1 Company Basic Information

6.19.2 Mitoxantrone (Specification and Price)

6.19.3 Sales Value, Gross Margin 2011-2016

6.19.4 Interviewee, Name and Contact

6.20 Jiangsu Aosaikang Pharmaceutical

6.20.1 Company Basic Information

6.20.2 Mitoxantrone (Specification and Price)

6.20.3 Sales Value, Gross Margin 2011-2016

6.20.4 Interviewee, Name and Contact

6.21 JIANG SU HENG RUI MEDICINE

6.21.1 Company Basic Information

6.21.2 Mitoxantrone (Specification and Price)

6.21.3 Sales Value, Gross Margin 2011-2016

6.21.4 Interviewee, Name and Contact

6.22 Johnson

6.22.1 Company Basic Information

6.22.2 Zytiga (Specification and Price)

6.22.3 Sales Value, Gross Margin 2011-2016

6.22.4 Interviewee, Name and Contact

6.23 Astellas

6.23.1 Company Basic Information

6.23.2 Xtandi (Specification and Price)

6.23.3 Sales Value, Gross Margin 2011-2016

6.23.4 Interviewee, Name and Contact

7 Technology Development Trend

7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer

7.2 Analysis of Manufacturing Process

7.3 Development Trend

8 Research Findings and Conclusion

Figure Picture of Drugs for Prostate Cancer 17

Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17

Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 17

Figure Russia Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17

Figure Russia Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18

Figure Brazil Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18

Figure Brazil Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18

Figure Japan Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18

Figure Japan Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18

Table Product Type of Key Manufacturers 18

Table Price List and Forecast of Each Type 19

Table Market Share of Each Type 19

Figure Growth Rate of Each Type 2014 to 2015 20

Figure Picture of Triptorelin 20

Table Specification of Triptorelin 20

Figure Picture of Leuprorelin 20

Table Specification of Leuprorelin 20

Figure Picture of Flutamide Tablets 21

Table Specification of Flutamide Tablets 21

Figure Picture of Goserelin 21

Table Specification of Goserelin 21

Figure Picture of Bicalutamide Tablets 21

Table Specification of Bicalutamide Tablets 21

Figure Picture of Type Bicalutamide Capsules 21

Table Specification of Type Bicalutamide Capsules 21

Figure Picture of Estramustine Phosphate Capsules 22

Table Specification of Estramustine Phosphate Capsules 22

Figure Picture of Mitoxantrone 22

Table Specification of Mitoxantrone 22

Figure Picture of Zytiga 22

Table Specification of Zytiga 22

Figure Picture of Xtandi 22

Table Specification of Xtandi 23

Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016 23

Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016 23

Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24

Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24

Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016 25

Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016 25

Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26

Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26

Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016 27

Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016 27

Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016 28

Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016 28

Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 29

Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 29

Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 30

Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 30

Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 31

Table Russia Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 32

Table Russia Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 32

Table Russia Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 33

Table Russia Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 33

Table Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 34

Table Brazil Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 34

Table Brazil Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 35

Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 35

Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 36

Table Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 36

Table Japan Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 37

Table Japan Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 37

Table Japan Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 38

Table Japan Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 39

Table Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 39

Table China Sales of Each Type 2010 to 2015 40

Table China Sales Market Share of Each Type 2010 to 2015 40

Table China Sales Growth Rate of Each Type 2015 to 2016 40

Table China Revenue of Each Type 2015 to 2016 41

Table China Revenue Market Share of Each Type 2015 to 2016 41

Table China Revenue of Each Type 2015 to 2016 41

Table China Revenue Market Share of Each Type 2015 to 2016 42

Table Global Sales of Each Type 2015 to 2016 42

Table Russia Sales Market Share of Each Type 2015 to 2016 42

Table Global Sales Growth Rate of Each Type 2015 to 2016 42

Table Global Revenue of Each Type 2015 to 2016 43

Table Russia Revenue Market Share of Each Type 2015 to 2016 43

Table Russia Revenue of Each Type 2015 to 2016 43

Table Russia Revenue Market Share of Each Type 2015 to 2016 44

Table Brazil Sales of Each Type 2015 to 2016 44

Table Brazil Sales Market Share of Each Type 2015 to 2016 44

Table Brazil Sales Growth Rate of Each Type 2015 to 2016 45

Table Brazil Revenue of Each Type 2015 to 2016 45

Table Brazil Revenue Market Share of Each Type 2015 to 2016 45

Table Brazil Revenue of Each Type 2015 to 2016 45

Table Brazil Revenue Market Share of Each Type 2015 to 2016 46

Table Japan Sales of Each Type 2015 to 2016 46

Table Japan Sales Market Share of Each Type 2015 to 2016 46

Table Japan Sales Growth Rate of Each Type 2015 to 2016 47

Table Japan Revenue of Each Type 2015 to 2016 47

Table Japan Revenue Market Share of Each Type 2015 to 2016 47

Table Japan Revenue of Each Type 2015 to 2016 47

Table Japan Revenue Market Share of Each Type 2015 to 2016 48

Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 49

Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 50

Table Key Raw Materials for Triptorelin 51

Table Price Forecast of Key Raw Materials for Triptorelin 51

Table Key Raw Materials for Leuprorelin 52

Table Price Forecast of Key Raw Materials for Leuprorelin 52

Table Key Raw Materials for Flutamide Tablets 52

Table Price Forecast of Key Raw Materials for Flutamide Tablets 53

Table Key Raw Materials for Goserelin 53

Table Price Forecast of Key Raw Materials for Goserelin 53

Table Key Raw Materials for Bicalutamide Tablets 54

Table Price Forecast of Key Raw Materials for Bicalutamide Tablets 54

Table Key Raw Materials for Bicalutamide Capsules 55

Table Price Forecast of Key Raw Materials for Bicalutamide Capsules 55

Table Key Raw Materials for Estramustine Phosphate Capsules 55

Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 56

Table Key Raw Materials for Mitoxantrone 56

Table Price Forecast of Key Raw Materials for Mitoxantrone 57

Table Key Raw Materials for Zytiga 57

Table Price Forecast of Key Raw Materials for Zytiga 57

Table Key Raw Materials for Xtandi 58

Table Price Forecast of Key Raw Materials for Zytiga 58

Table Applications of Triptorelin 58

Table Applications of Leuprorelin 59

Table Applications of Flutamide Tablets 59

Table Applications of Goserelin 59

Table Applications of Bicalutamide Tablets 59

Table Applications of Bicalutamide Capsules 60

Table Applications of Estramustine Phosphate Capsules 60

Table Applications of Mitoxantrone 60

Table Applications of Zytiga 61

Table Applications of Xtandi 61

Table IPSEN Basic Information List 62

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of IPSEN 62

Table Sales Value, Gross Margin and Growth rate of IPSEN in China 62

Figure Product Sales Value, Growth rate of IPSEN in China 63

Table Sales Value, Gross Margin and Growth rate of IPSEN in Russia 63

Figure Product Sales Value, Growth rate of IPSEN in Russia 63

Table Sales Value, Gross Margin and Growth rate of IPSEN in Brazil 63

Figure Product Sales Value, Growth rate of IPSEN in Brazil 63

Table Sales Value, Gross Margin and Growth rate of IPSEN in Japan 63

Figure Product Sales Value, Growth rate of IPSEN in Japan 64

Table Ferring Pharmaceuticals Basic Information List 64

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Ferring Pharmaceuticals 64

Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in China 65

Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in China 65

Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Russia 65

Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Russia 65

Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Brazil 65

Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Brazil 65

Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Japan 66

Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Japan 66

Table Chengdu Tiantaishan pharmaceutical Basic Information List 66

Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical in China 67

Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical in China 67

Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical in China 67

Table GeneScience Pharmaceuticals Basic Information List 67

Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals in China 68

Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals in China 68

Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals in China 68

Table Takeda Pharmaceutical Company Limited Basic Information List 69

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Takeda Pharmaceutical Company Limited 69

Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in China 69

Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in China 70

Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Russia 70

Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Russia 70

Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70

Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70

Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Japan 70

Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Japan 71

Table Beijing Biote Pharmaceutical Basic Information List 71

Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical in China 71

Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical in China 72

Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical in China 72

Table Livzon Pharmaceutical Group Basic Information List 72

Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group in China 73

Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group in China 73

Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group in China 73

Table Schering-Plough Canada Basic Information List 73

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Schering-Plough Canada 74

Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in China 74

Figure Product Sales Value, Growth rate of Schering-Plough Canada in China 74

Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Russia 74

Figure Product Sales Value, Growth rate of Schering-Plough Canada in Russia 75

Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Brazil 75

Figure Product Sales Value, Growth rate of Schering-Plough Canada in Brazil 75

Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Japan 75

Figure Product Sales Value, Growth rate of Schering-Plough Canada in Japan 75

Table JiangSu TASLY DI YI Pharmaceutical Basic Information List 76

Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical in China 76

Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 76

Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 77

Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List 77

Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical in China 77

Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78

Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78

Table S.C.SINDAN-PHARMA S.R.L. Basic Information List 78

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of S.C.SINDAN-PHARMA S.R.L. 79

Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79

Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79

Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79

Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79

Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80

Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80

Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80

Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80

Table AstraZeneca Basic Information List 80

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 81

Table Sales Value, Gross Margin and Growth rate of AstraZeneca in China 81

Figure Product Sales Value, Growth rate of AstraZeneca in China 81

Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Russia 81

Figure Product Sales Value, Growth rate of AstraZeneca in Russia 82

Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Brazil 82

Figure Product Sales Value, Growth rate of AstraZeneca in Brazil 82

Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Japan 82

Figure Product Sales Value, Growth rate of AstraZeneca in Japan 82

Table Corden Pharma GmbH Basic Information List 83

Table Specification, Price, Sales Value(China, Russia, Brazil and Japan)and Market Share of Corden Pharma GmbH 83

Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in China 83

Figure Product Sales Value, Growth rate of Corden Pharma GmbH in China 84

Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Russia 84

Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Russia 84

Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Brazil 84

Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Brazil 84

Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Japan 84

Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Japan 85

Table Shanghai Zhaohui Pharmaceutical Basic Information List 85

Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical in China 85

Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical in China 86

Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical in China 86

Table HISUN Pharmaceutical Basic Information List 86

Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical in China 87

Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical in China 87

Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical in China 87

Table Shanxi Zhendong Pharmaceutical Basic Information List 87

Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical in China 88

Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical in China 88

Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical in China 88

Table Pfizer Basic Information List 89

Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 89

Table Sales Value, Gross Margin and Growth rate of Pfizer in China 89

Figure Product Sales Value, Growth rate of Pfizer in China 90

Table Sales Value, Gross Margin and Growth rate of Pfizer in Russia 90

Figure Product Sales Value, Growth rate of Pfizer in Russia 90

Table Sales Value, Gross Margin and Growth rate of Pfizer in Brazil 90

Figure Product Sales Value, Growth rate of Pfizer in Brazil 90

Table Sales Value, Gross Margin and Growth rate of Pfizer in Japan 90

Figure Product Sales Value, Growth rate of Pfizer in Japan 90

Table Sichuan sunnyhope pharmaceutical Basic Information List 91

Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical in China 91

Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical in China 91

Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical in China 92

Table Luoxin Group Basic Information List 92

Table Specification, Price, Sales Value and Market Share of Luoxin Group in China 92

Table Sales Value, Gross Margin and Growth rate of Luoxin Group in China 93

Figure Product Sales Value, Growth rate of Luoxin Group in China 93

Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 93

Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical in China 94

Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical in China 94

Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical 94

Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 94

Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE in China 95

Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE China 95

Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE in China 95

Table Johnson Basic Information List 96

Table Specification, Price, Sales Value and Market Share of Johnson in Japan 96

Table Sales Value, Gross Margin and Growth rate of Johnson in Japan 96

Figure Product Sales Value, Growth rate of Johnson in Japan 96

Table Sales Value, Gross Margin and Growth rate of Johnson in Russia 97

Figure Product Sales Value, Growth rate of Johnson in Russia 97

Table Astellas Basic Information List 97

Table Specification, Price, Sales Value and Market Share of Astellas in Japan 97

Table Sales Value, Gross Margin and Growth rate of Astellas in Japan 98

Figure Product Sales Value, Growth rate of Astellas in Japan 98